Postdoctoral Fellow Binita Chakraborty, PhD was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standard of care, the treatment worked better in men than in women.

Turning a Terrifying Ordeal into an Opportunity to Help

When reports early last winter indicated that a mysterious new infectious disease had broken out of its point of origin in Wuhan, China, Charles Lucore, MD’83, P’17, MBA, began to prepare for its possible arrival in New York.

Twin 9-year-old girls at Duke Health became the first in the United States to participate in a Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 among healthy children below the age of 12.